Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146 | 29 | 32 | 63 | 293 |
| Receivables | 51 | 159 | 154 | 161 | 138 |
| TOTAL | $198 | $188 | $186 | $224 | $431 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 0 | 80 | 87 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Intangibles | N/A | 0 | 371 | 371 | 371 |
| Other Non-Current Assets | 0 | 0 | 193 | 178 | 175 |
| TOTAL | $50 | $50 | $614 | $679 | $683 |
| Total Assets | $248 | $238 | $800 | $902 | $1,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 126 | 126 | 571 | 549 | 526 |
| Accounts payable and accrued liabilities | 348 | 242 | N/A | N/A | 75 |
| TOTAL | $474 | $367 | $677 | $609 | $631 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $9 | $74 | $82 |
| Total Liabilities | $474 | $367 | $686 | $683 | $713 |
| Shareholders' Equity | |||||
| Common Shares | 4,523 | 4,523 | 4,029 | 4,029 | 4,027 |
| Retained earnings | -4,921 | -4,823 | -4,117 | -4,013 | -3,829 |
| Other shareholders' equity | 162 | 162 | 162 | 162 | 162 |
| TOTAL | $-227 | $-129 | $115 | $219 | $400 |
| Total Liabilities And Equity | $248 | $238 | $800 | $902 | $1,114 |